Physician profile
Bridget Mucha
NPI 1760092001
$1,094.18
in general payments reported to CMS, 2019-2025
22 companies · $16.57 in 2025
The $16.57 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $325 · 2023: $453 · 2024: $120 · 2025: $16.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $243.89 | 2021-2024 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals Lp | $219.30 | 2023-2024 | Breztri, Airsupra |
| Novo Nordisk INC | $106.85 | 2022-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $76.93 | 2022-2023 | |
| Lilly USA, LLC | $74.15 | 2022-2023 | Mounjaro |
| Pfizer INC. | $52.25 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $33.55 | 2022-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Grifols USA, LLC | $28.65 | 2022 | |
| Glaxosmithkline, LLC. | $28.41 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.91 | 2021 | |
| Xeris Pharmaceuticals, INC. | $22.77 | 2023 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $21.28 | 2021 | |
| Exact Sciences Corporation | $20.46 | 2023 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $19.46 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.75 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.57 | 2025 | Durolane |
| Vbi Vaccine (Delaware) INC. | $15.72 | 2023 | Prehevbrio |
| Janssen Pharmaceuticals, INC | $15.48 | 2024 | Xarelto |
| Depuy Synthes Sales INC. | $15.38 | 2024 | Monovisc |
| Idorsia Pharmaceuticals US INC | $15.22 | 2023 | Quviviq |
| Horizon Therapeutics Plc | $14.33 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Mucha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.